ICOSLG antibody (Extracellular Domain)
Quick Overview for ICOSLG antibody (Extracellular Domain) (ABIN108723)
Target
See all ICOSLG AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- Extracellular Domain
-
Specificity
- GM13C1 recognises the extracellular domain of ICOSL transiently expressed on the cell surface of transfected BOSC cells as well as the native protein on antigen presenting cells (see reference).
-
Purification
- Protein G
-
Immunogen
- genetic immunisation with cDNA encoding human ICOSL (extracellular domain)
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
Flow cytometry: 1.2 µg/10^6 cells
CELISA: 1:200 - 1:400
For each application a titration should be performed to determine the optimal concentration. -
Comment
-
Synonyms: ICOS ligand
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS, pH 7.2
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C
-
Storage Comment
- short term: 2 °C - 8 °C, long term: -20 °C
-
-
- ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
-
Alternative Name
- ICOSL
-
Background
- The inducible co-stimulator receptor (ICOS) is a member of the CD28 receptor family that is expressed on T cells. ICOS ligand (ICOSL) has been identified as a ligand that binds to ICOS, but not to CD28 or CTLA4. GM13C1 was generated by genetic immunisation and recognises the extracellular domain of ICOSL.
-
UniProt
- O75144
-
Pathways
- Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
Target
-